Mapping Pharmacologically-induced Functional Reorganisation onto the Brain's Neurotransmitter Landscape
Andrea I. LuppiiD, Justine Y. HanseniD, R. AdapaiD, Robin Lester Carhart-HarrisiD, Leor RosemaniD, Christopher TimmermanniD, Daniel GolkowskiiD, Andreas RanftiD, Rüdiger Ilg, Denis JordaniD, Vincent Luce BonhommeiD, Audrey VanhaudenhuyseiD, Athena Demertzi AiD, Océane JaquetiD, Mohamed Ali BahriiD, Naji AlnaggeriD, Paolo CardoneiD, Alexander R. D. PeattieiD, Anne E. ManktelowiD, Dráulio Barros de AraújoiD, Stefano Luca SensiiD, Adrian Mark OweniD, Lorina NaçiiD, David Krishna MenoniD, Bratislav MišićiD, Emmanuel Andreas StamatakisiD
Abstract
To understand how pharmacological interventions can exert their powerful effects on brain function, we need to understand how they engage the brains rich neurotransmitter landscape. Here, we bridge microscale molecular chemoarchitecture and pharmacologically-induced macroscale functional reorganisation, by relating the regional distribution of 19 neurotransmitter receptors and transporters obtained from Positron Emission Tomography, and the regional changes in functional MRI connectivity induced by 10 different mind-altering drugs: propofol, sevoflurane, ketamine, LSD, psilocybin, DMT, ayahuasca, MDMA, modafinil, and methylphenidate. Our results reveal that psychoactive drugs exert their effects on brain function by engaging multiple neurotransmitter systems. The effects of both anaesthetics and psychedelics on brain function are organised along hierarchical gradients of brain structure and function. Finally, we show that regional co-susceptibility to pharmacological interventions recapitulates co-susceptibility to disorder-induced structural alterations. Collectively, these results highlight rich statistical patterns relating molecular chemoarchitecture and drug-induced reorganisation of the brains functional architecture.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Mesoscale Framework for Psychedelic Drug Action in the Human Brain
Rui Dai, Rodrigo Cofré, … George A. Mashour·bioRxiv·Nov 23, 2025
- Psychedelics Restructure the Global Workspace of Consciousness
Parsa Yousefi, Kenneth Shinozuka, … Pedro A. M. Mediano·bioRxiv·Oct 5, 2026
- Canonical and Non-Canonical Psychedelic Drugs Induce Common Network Changes in Human Cortex
Rui Dai, Tony E. Larkin, … George A. Mashour·bioRxiv·Oct 14, 2022
- Unravelling the effects of methylphenidate on the dopaminergic and noradrenergic functional circuits
Ottavia Dipasquale, Daniel Martins, … Mara Cercignani·NeuropsychopharmacologyPeer-reviewed·May 30, 2020
- Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology
Kenneth Shinozuka, Katarina Jerotic, … Morten L. Kringelbach·Translational PsychiatryPeer-reviewed·Dec 4, 2024
- Trips and Neurotransmitters: Discovering Principled Patterns across 6,850 Hallucinogenic Experiences
Galen Ballentine, Sam Freesun Friedman, Danilo Bzdok·Science AdvancesPeer-reviewed·Mar 16, 2022